Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

← Back to all medicines

Boots Pain Relief Heat Spray

⚠ This medicine appears to have been discontinued

The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.

If you were prescribed this medicine, other products containing Methyl salicylate, Ethyl nicotinate, Racemic camphor may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.

Active substance: Methyl salicylate, Ethyl nicotinate, Racemic camphor
Source: electronic medicines compendium (emc)
Official leaflet: Read the PIL on emc

Possible side effects

not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.

Active ingredients This topical sprays contains Ethyl Nicotinate 1.1% w/w, Methyl Salicylate 1.25% w/w, Racemic Camphor 0.625% w/w. Also contains: denatured ethanol, butane, isobutane, propane. Keep all medicines out of the sight and reach of children. Use by the date on the base of the can. PL 00014/0275 Text prepared 9/14 Manufactured for the Marketing Authorisation holder The Boots Company PLC Nottingham NG2 3AA by Colep Laupheim GmbH & Co. KG Fockestr. 12 88471 Laupheim Germany Danger: Extremely flammable aerosol. Pressurised container: May burst if heated. Keep away from heat, hot surfaces, sparks, open flames or any incandescent material and other ignition sources. No smoking. Do not pierce or burn, even after use. Do not use near or place on painted or polished surfaces. Protect from sunlight. Do not expose to temperatures above 50° C/122°F. If you need more advice ask your pharmacist EXTREMELY FLAMMABLE Artwork reference WBAG412877

Frequently asked questions about Boots Pain Relief Heat Spray

How do I take Boots Pain Relief Heat Spray?

Boots Pain Relief Heat Spray comes as spray. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.

What is the active substance in Boots Pain Relief Heat Spray?

The active substance in Boots Pain Relief Heat Spray is methyl salicylate, ethyl nicotinate, racemic camphor.

Where does this information come from?

This leaflet reproduces the patient information leaflet approved for Boots Pain Relief Heat Spray, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.

Can I get Boots Pain Relief Heat Spray without a prescription?

Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.

About this leaflet

The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.

  • Source: electronic medicines compendium (emc), Datapharm
  • Active substance: methyl salicylate, ethyl nicotinate, racemic camphor
  • Official document: view the original leaflet on emc →
Medical disclaimer: This page is for information only and does not replace advice from your doctor or pharmacist. Always read the leaflet supplied with your medicine. If you are unwell, call NHS 111; in an emergency, call 999.

Medicines with the same active substance: Methyl salicylate (4 medicines), Methyl salicylate, ethyl nicotinate, racemic camphor (1 medicine)
See every medicine containing this substance, or browse the full A–Z of active substances.
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
Technical information intended for healthcare professionals (doctors and pharmacists). The Summary of Product Characteristics (SmPC) is the official document approved by the MHRA/EMA. It does not replace the patient leaflet or a doctor’s advice.

4.1. Therapeutic indications

For the relief of muscular and rheumatic pains, lumbago, fibrositis, sciatica, sprains, strains and stiffness.

For topical administration.

4.2. Posology and method of administration

Adults and children over 5 years: Spray the site of pain using 2 or 3 short bursts, holding the container about 6 inches (15cm) from the skin.

Children under 5 years: Not to be used by children under 5 years.

Elderly: The normal adult dose is still appropriate in the elderly.

4.3. Contraindications

Hypersensitivity to any of the ingredients.

Children under 5 years.

4.4. Special warnings and precautions for use

For external use only.

Use sparingly as over-application can cause discomfort.

Discontinue use of the product if excessive irritation occurs.

Keep away from the eyes, face, mucous membranes and other sensitive parts of the body.

Do not use on broken or damaged skin or on open cuts.

If symptoms persist, consult your doctor.

Avoid inhalation.

Keep all medicines out of the reach of children.

4.5. Interaction with other medicinal products and other forms of interaction

No clinically significant drug interactions known.

4.6. Pregnancy and lactation

Although there are no data available to support the use of this product during pregnancy and lactation it is unlikely that use of this product would constitute a hazard to the foetus or breast fed infant.

4.7. Effects on ability to drive and use machines

No adverse effect known.

4.8. Undesirable effects

Occasional hypersensitivity reactions.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.

4.9. Overdose

It is unlikely that overdosage will occur, but in the event, symptomatic treatment only should be sufficient.

🇵🇱 Known in Poland as

Medicines sold in Poland with the same active substance: W Polsce znany jako

⚠ Not the same combination. This medicine contains Methyl salicylate, Ethyl nicotinate, Racemic camphor. The products below do not contain exactly the same set of active substances — they are not direct substitutes.

⚠ Same active substance, but a different pharmaceutical form (for example a gel instead of a tablet). Not interchangeable — ask a pharmacist.

  • Unguentum Camphoratum partial — not the same combinationCamphora · skin / topical

Some of these do not contain exactly the same active substances — check each one. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →

💬 Ask about this leaflet

Ask anything about Boots Pain Relief Heat Spray. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.

Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.

Pharmacies in major towns and cities — see the list
Pharmacies by county and region — see the full list

Browse all 2,009 towns and cities →